Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 2nd International Conference and Exhibition on Dental and Oral Health Dubai, UAE.

Day 1 :

Keynote Forum

Sammy Noumbissi

International Academy of Ceremic Implantology, USA

Keynote: All Ceramic Implantology with Zirconia Dental Implants: Rationale, Case Selection, Treatment Planning and Clinical outcomes

Time : 10:35-11:00

OMICS International Dental-2014 International Conference Keynote Speaker Sammy Noumbissi photo
Biography:

Sammy Noumbissi obtained his Doctorate in Dental Surgery from Howard University in Washington DC. He then attended Loma Linda University where he received three years of formal training in Implant Dentistry which culminated with a certificate and a Master of Science degree in Implant Dentistry. He has published abstracts and articles in peer reviewed dental journals namely the Journal of Dental Research, the Journal of Oral Implantology and the Journal of Implant and Clinical Dentistry. He is a member of the editorial board of the Journal of Implant and Advanced Clinical Dentistry, the Dentistry and Medical Online Journal, a reviewer for the Journal of Oral Implantology and the current president for the International Academy of Ceramic Implantology. Dr. Noumbissi is the founder, current owner and president of Miles of Smiles Institute for Implant Dentistry LLC, a holistic dental implantology practice that delivers advanced education and patient care in state of the art metal-free dental implantology. He practices in Silver Spring, Maryland USA.

Abstract:

Following in the footsteps of medical orthopedics, the last decade has seen zirconia the tetragonal crystal phase of zirconium become an acceptable and proven material of choice in dentistry. Zirconia abutments on metal implants have been widely used especially when aesthetics are of concern mainly because of the exceptional soft tissue response. Reaseach is increasingly proving that not all patients are physiologically able to accept or tolerate metal implants as such the search for an alternative to titanium and titanium alloy implants has been active for over twenty years. Bioceramics such as Y-TZP Zirconia have emerged as the alternative of choice in dental implantology. Zirconia is an inert bioceramic which has excellent biomechanical properties, does not conduct heat, retains no plaque and it is not susceptible to galvanic activity or corrosion in the oral environment. Most ceramic implants today are one-piece therefore case planning, surgical technique, post-surgical monitoring, restorative options and materials are critical for long term case success. This presentation will first cover zirconia as an implant material and the reasons why and instances when it should be the material of choice for implantation. Second through clinical case presentations decision trees on case selection, treatment planning and surgical protocol will be presented.

Keynote Forum

Dave Singh

BioModeling Solutions, USA

Keynote: Changes in 3D nasal volume after biomimetic oral appliance therapy in adults

Time : 11:00-11:25

OMICS International Dental-2014 International Conference Keynote Speaker Dave Singh  photo
Biography:

G. Dave Singh was born, educated and trained in England. He is currently Chairman of BioModeling Solutions, USA. Previously, he was a Visiting Professor in Orthodontics (Malaysia and Indonesia), Associate Professor at the University of Puerto Rico, USA, and Director of Continuing Education, SMILE Foundation, USA. He has been published extensively in the orthodontic and dental literature, and has co-authored several books. He is also Senior Instructor/Consultant/Fellow of the International Association for Orthodontics; Academic Fellow of the World Federation of Orthodontists; and a Member of the American Academy of Dental Sleep Medicine.

Abstract:

Introduction: Although continuous positive airway pressure (CPAP) is recommended as the first line of treatment for obstructive sleep apnea, patient compliance is often the limiting factor in terms of treatment success. Poor compliance may be a consequence of nasal obstruction, which requires higher CPAP pressures to overcome nasal resistance. Indeed, if the nasal airway volume could be increased, patient compliance with CPAP might be improved. Therefore, in this preliminary study we investigated 3D changes in nasal volume, to test the null hypothesis that nasal cavity volume cannot be changed in non-growing adults. Methods: After obtaining informed consent, we undertook 3D cone-beam computerized axial scans of 11 consecutive, adult patients (mean age 37.9 yrs) prior to and after biomimetic, oral appliance therapy. These cases had all been diagnosed with midfacial underdevelopment. The mean treatment time was 18.4 months ± 2.5. Volumetric reconstruction of the nasal cavity was undertaken between the anterior and posterior nasal spines, extending superiorly from the palatine process of the maxilla and the palatine bone to the cribriform plate of the ethmoid bone. Next, the nasal cavity volume was calculated in all cases. The findings were subjected to statistical analysis, using paired t-tests. Results: The mean nasal cavity volume was 41.9cm3 ± 12.1 prior to treatment. After oral appliance therapy, the mean nasal cavity volume increased to 44.0cm3 ± 12.1 (p = 0.022). Conclusions: These data support the notion that nasal cavity volume can be changed in non-growing adults. Therefore, use of a biomimetic oral appliance prior to, or in conjunction with, CPAP therapy might potentially improve CPAP compliance in adults diagnosed with obstructive sleep apnea by increasing the nasal cavity volume and decreasing nasal airflow resistance. \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\r\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\n

Keynote Forum

Ninian Peckitt

Nicolas and Asp Center
European University College
UAE

Keynote: Engineering Assisted Surgery™ - The Gold Standard in Personalised Care

Time : 11:00-11:25

OMICS International Dental-2014 International Conference Keynote Speaker Ninian Peckitt photo
Biography:

Ninian Peckitt has worked in this research area for 20 years and has an international reputation in this area of expertise. His lectures employ sophisticated multi-media technology to describe the planning and management of cases, some of which are very complex. In this lecture, the reconstruction of the entire midface, including the dentition, is demonstrated as a day case procedure in a surgical procedure lasting only 90 mins. He regularly lectures by invitation and is moving his Training and Research base to the European University College, and his clinical practice to the Nicolas and Asp Clinic, in Dubai.

Abstract:

Successful clinical interventions rely heavily on human qualities of the clinician, and an association with inaccurate replication and transfer of 2-D treatment plans into patients with three dimensions. Modern Healthcare is the only and last High Tech Industry which still depends on human frailty and the manual skills of its workforce – skill requirements that have long been abandoned by sister industries. \\\\\\\\\\\\\\\\r\\\\\\\\\\\\\\\\nEngineering Assisted Surgery™ (EAS) is defined as “the application of industrial and engineering systems to health care delivery” with respect to existing interventions and new/evolving surgical procedures, across a range of specialities.\\\\\\\\\\\\\\\\r\\\\\\\\\\\\\\\\nEAS has important applications related to current surgical practice, and the recent introduction of additive manufacturing, permits mass production of both standard and customised medical devices/implants at much lower cost, and is set to revolutionise surgical practice. It is predicted that customisation will become the norm in personalised healthcare programmes within the next decade.\\\\\\\\\\\\\\\\r\\\\\\\\\\\\\\\\nHealthcare is in the perfect position to benefit from these advances made by adopting customisation, and in particular additive manufacturing technologies, to support the surgeons in delivering improved and consistent outcomes for patients.\\\\\\\\\\\\\\\\r\\\\\\\\\\\\\\\\nEAS heralds new gold standards in the provision of global healthcare, with an improvement in efficiency, quality and outcome, already seen in other industries, and not only promotes the concept of best practice; it makes best practice a reality.\\\\\\\\\\\\\\\\r\\\\\\\\\\\\\\\\nThe value of an industrial contribution to healthcare modernisation has been now internationally recognised. However, such a process can only be effectively implemented within EAS Training Centres of Excellence, and in partnership with concomitant reforms in healthcare policy, funding, management and delivery.\\\\\\\\\\\\\\\\r\\\\\\\\\\\\\\\\nEAS™ provides an evidence based and efficacious industrial model on which to build modernised healthcare systems, which are currently under so much pressure, and therefore such programmes require utmost priority.\\\\\\\\\\\\\\\\r\\\\\\\\\\\\\\\\n

Keynote Forum

James L. Ratcliff

Rowpar Pharmaceuticals
USA

Keynote: Time’s arrow in the treatment of oral and systemic disease

Time : 10:35-11:00

OMICS International Dental-2014 International Conference Keynote Speaker James L. Ratcliff photo
Biography:

James L Ratcliff is Chairman and CEO of Rowpar Pharmaceuticals, Scottsdale, AZ, makers of the ClōSYS and Dentists’ Choice brands of oral care products. Prior to assuming his current role, he was Professor and senior Scientist at the Center for Higher Education at the Pennsylvania State University (1990-2000), Professor of higher education at the Iowa State University (1979-1989), President of Performance Associates Consultants (1976 to present), Associate Professor, Florida Atlantic University (1977-1978) and Assistant Professor, Washington State University (1975-77). He is author of over two dozen books and over hundred articles and has consulted with universities, research centers and higher education agencies on six continents. He is co-inventor with Elena Young of a patent application entitled, “Method for prevention and treatment of oral fungal infections”.

Abstract:

What does research into patient behavior and home oral care products teach us about the role of time and timing in patient treatment protocols? Drawing on product development research and consumer research, Dr. Ratcliff examines the intersection between dental treatment and prevention protocols, patient home oral care practices, and the selection of chemotherapeutic agents in therapy and prevention, challenging conventions in patient treatment protocols and home oral care. The influence of commercial advertising on patient expectations and professional practices are also discussed, as well as the role of the dental professional in improving patient outcomes. The implications and findings of research and theory for patient treatment protocols for oral disease, patient education, and home oral care practices are presented.

Break: Coffee Break @ Ball Room Foyer

Keynote Forum

Isabel Rambob

University of Maryland School of Dentistry
USA

Keynote: HIV, TB & smoking

Time : 11:00-11:25

OMICS International Dental-2014 International Conference Keynote Speaker Isabel Rambob photo
Biography:

Isabel Rambob received her Doctor of Dental Surgery degree from the State University of Feira de Santana, Brazil in 1997. She completed a one-year program in Advanced Education in Comprehensive Dentistry at New York University College of Dentistry in 2007. She then pursued and completed a one-year Residency Program in Advanced Education in General Dentistry at Howard University College of Dentistry in 2008. She was a dental provider at HIV+ clinic and a clinical instructor at Special Needs clinic at University of Maryland School of Dentistry from 2009-2012. She was the dental director at National Minority AIDS Education and Training Center from 2009-2010. She was a HIV/AIDS & oral health preceptor at Howard University College of Medicine from 2009-2010. She was the dental director at Health Care for the Homeless, Maryland from 2010-2011. Currently, she is an assistant Professor at University of Maryland School of Dentistry at the Department of General Dentistry. She is also a guest lecturer at New York University College of Dentistry, Howard University College of Dentistry and VA Medical Center, Baltimore. \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\r\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\n\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\r\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\n

Abstract:

Since the beginning of the 21st century, we are facing the convergence of several epidemics. These include tobacco smoking, tuberculosis (TB) and HIV infection. These epidemics interact by way of increasing disease susceptibility and worsening outcomes. To control these interacting epidemics, it is crucial to better understand each infection and how it influences the others. The association between tobacco smoke and TB was suggested many years ago. Evidence of the impact of tobacco smoking on TB infection has been confounded by its almost universal association with poverty, overcrowding and alcohol usage. Similar pathological mechanisms induced by malnutrition, alcohol abuse and smoking may indeed all predispose an individual to TB. Although both tobacco smoking and HIV infection may be associated through their common associations with poverty and high-risk behavior, tobacco smoking appears to be an independent and important risk factor for contracting HIV. Smoking further raises the extremely high risk of contracting TB in HIV+ individuals. The overall goal of this presentation is to focus on HIV disease, TB and smoking in their impact on the oral health. Tobacco use in HIV+ smokers is responsible for increased periodontal disease and tooth loss. Also HIV+ smokers have an increased incidence of cancer of the larynx, pharynx and esophagus. Smokers have an increased risk of oral candidiasis and oral leukoplakia, as well as decreasing healing of oral lesions. There is a marked risk of oral cancer in tobacco users and more than 80% is squamous cell carcinoma. Therefore dental professionals should play an important role in preventing these epidemics. \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\r\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\n